Seattle, WA (PRWEB) May 09, 2013
It was a good month for job seekers as April's Employment Situation Report gave them much to celebrate. Job cuts in April were also reported to have hit their lowest level since December, and 23% lower than March. (challengergray.com, 5/2/2013) While the unemployment rate has been steadily declining over the past four years, the real excitement is in the report that in April the number of long-term unemployed was reduced by more than a quarter of a million people. According to Acting Secretary of Labor Seth D. Harris many of these job gains were made in professional services such as healthcare and business services showing that the recovery efforts are restoring multi-level infrastructure throughout the economic levels, including the middle class. (prnewswire.com, 5/3/2013)
"This is good news all around, no matter how you look at it. More people out there in the workforce means more people who are able to contribute to the overall economy. Even the Commerce Department was able to report that consumer spending was up last month. This is good for everyone and as spending increases, individuals and businesses can afford to invest more into research and development. As they do, they need more tech and science employees, which is exactly what we're beginning to see. It's great news for everyone," said, Del Johnston, Manager of Client Relations at MedZilla.com.
Dr. Will Shu and the Biomedical Micro-Engineering Group at Heriot-Watt University, in partnership with Roslin Cellab, have made international headlines by using the 3D printing methods with a new valve technique and turning out some unexpected and amazing results for the pharmaceutical industry. Under normal laboratory conditions, a range of human stem cell cultures can be grown from previously established cell lines taken from adult tissue, such as bone marrow or skin cells. While those cells are more resilient, they are less malleable than embryonic stem cells.
3D printing and replication of these more robust stem cells has been accomplished before. Dr. Shu's group, using this new technique, has now been able to replicate embryonic stem cells, the difference here being that these cells have the ability to replicate indefinitely. They can separate and become nearly any cell type in the body.
The innovators behind this creation believe that these specialized techniques will eventually lead to many long term practical applications throughout the Healthcare, Scientific, Research and Pharmaceutical Industries. They see this as a starting point which may eventually lead to animal-free drug testing, and specialized pharmaceutical development. The unique process may prove valuable as a method for providing patients with the ability to receive transplant organs on demand, specifically tailored to their DNA, completely removing the current need for organ donors. Eliminating organ donation would mean the elimination of the complications which stymie its benefits, such as infection rates from suppressed immune response and outright organ rejection.
"This really is technological advancement at its finest. When 3D printing was first introduced many assumed that the uses would be limited to hardware and weapons manufacturing. However, it's beginning to look like biomedical uses may be the area of largest demand as well as the most practical, even in corporate terms. It is a great thing when scientific innovation can be used so directly and improve people's lives on such a scale. I really think we're only looking at tip of the iceberg of possibilities in the applications that we will eventually see from this. We get to watch as a new way of doing pharmaceutical research is being developed," said John Burkhardt Managing Director of MedZilla.com.
Medzilla.com is one of the most notable and essential resources for accessing and finding healthcare, pharmaceutical, and biotech employment information on the internet. Their employment experts connect real qualified and skilled workers with top industry employers.
Established in mid-1994, MedZilla is the original and leading web site to serve career and hiring needs for professionals and employers in biotechnology, pharmaceuticals, medicine, science and healthcare. The MedZilla jobs database contains about 7,500 open positions. The resume database currently contains over 295,000 resumes with 26,500 less than three months old. These resources have been characterized as the largest, most comprehensive databases of their kind on the web in the industries served.
MedZilla(R) is a Registered Trademark owned by MedZilla Inc. Copyright (C)MedZilla, Inc. Permission is granted to reproduce and distribute this text in its entirety, and if electronically, with a link to the URL http://www.medzilla.com. For permission to quote from or reproduce any portion of this message, please contact MedZilla, Inc. at press(at)medzilla(dot)com
Contact: MedZilla, Inc.
Phone: (360) 657-5681